Literature DB >> 8623773

Assessment of the role of GM-CSF in the cellular transformation and the development of erosive lesions around orthopaedic implants.

N Al-Saffar1, H A Khwaja, Y Kadoya, P A Revell.   

Abstract

Granulocyte-macrophage colony stimulating factor (GM-CSF) is a hematopoietic growth factor with a regulatory effect on the transformation of immature macrophages into multinucleated giant cells (MNGC) that exhibit phenotypic and functional characteristics of osteoclasts (OC). The authors analyzed the bone implant interface membranes harvested from 15 patients with failed total joint replacements for the production and tissue distribution of GM-CSF and interleukin-1 (IL-1). Immunohistology and liquid culture were employed to assess the contribution of these factors in the recruitment of macrophages and the development of bone resorbing MNGC at these sites. This process has been implicated in osteoclastic bone resorption, bone, and bone marrow necrosis adjacent to orthopaedic implants. Histologic assessment of the interface indicated the presence of granuloma and a variable number of MNGC in 11 cases. Four cases showed sites of intramembranous formation of osteoid and mineralized bone that was accompanied by normal bone marrow in two cases. Granulocyte-macrophage colony stimulating factor was expressed by a distinct subset of phagocytic macrophages in the lining layer on the implant side. interleukin-1-positive cells outnumbered those stained for GM-CSF. Stimulation of cultured cells with prosthetic metal particulate material showed marked similarity in the expression of these cytokines to cultures treated with lipopolysaccharide (LPS) or phytohemagglutinin (PHA). The induction of GM-CSF production in the lining layer where small MNGC develop indicates that these cells differentiate locally following the phagocytosis of particulate wear debris. In conclusion, GM-CSF promotes the proliferation and early stages of fusion and development of MNGC responsible for osteolysis at these sites. These results also highlight the capacity of the interface to display both osteogenic and inflammatory characteristics. Collectively, the findings suggest that the local bone marrow could participate in the development of the interface as a source of myeloid cells in addition to the capacity of marrow stroma to generate various osteogenic cells essential for the ingrowth of bone into prosthetic implants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623773     DOI: 10.1093/ajcp/105.5.628

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

1.  Inhibitory effect of (-)-epigallocatechin gallate on titanium particle-induced TNF-α release and in vivo osteolysis.

Authors:  Shan Jin; Ju Young Park; Jung Min Hong; Tae Ho Kim; Hong In Shin; Eui Kyun Park; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

2.  Comparison of the response of three human monocytic cell lines to challenge with polyethylene particles of known size and dose.

Authors:  J B Matthews; T R Green; M H Stone; B M Wroblewski; J Fisher; E Ingham
Journal:  J Mater Sci Mater Med       Date:  2001-03       Impact factor: 3.896

3.  Modulation of the phenotypic and functional properties of phagocytic macrophages by wear particles from orthopaedic implants.

Authors:  N Al-Saffar; P A Revell; A Kobayashi
Journal:  J Mater Sci Mater Med       Date:  1997-11       Impact factor: 3.896

Review 4.  The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses.

Authors:  Peter A Revell
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

5.  Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR).

Authors:  J W Xu; Y T Konttinen; V Waris; H Pätiälä; T Sorsa; S Santavirta
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

6.  Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts.

Authors:  K L Bost; J L Bento; J K Ellington; I Marriott; M C Hudson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.

Authors:  Ju Ang Kim; Hye Jung Ihn; Ju-Young Park; Jiwon Lim; Jung Min Hong; Sang Hyun Kim; Shin-Yoon Kim; Hong-In Shin; Eui Kyun Park
Journal:  Int Orthop       Date:  2014-11-23       Impact factor: 3.075

8.  Interleukin 15 production by macrophages in the implant interface membrane of aseptically loosened joint replacements.

Authors:  P A Revell; S E Jellie
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

Review 9.  How has the introduction of new bearing surfaces altered the biological reactions to byproducts of wear and modularity?

Authors:  Paul H Wooley
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

10.  T cell transgressions: Tales of T cell form and function in diverse disease states.

Authors:  Kevin M Harris; Madison A Clements; Andrew J Kwilasz; Linda R Watkins
Journal:  Int Rev Immunol       Date:  2021-06-21       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.